SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-16-026076
Filing Date
2016-02-26
Accepted
2016-02-25 17:36:33
Documents
81
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K vbiv20151231_10k.htm 10-K 1762970
2 EXHIBIT 32.2 ex32-2.htm EX-32.2 7047
3 EXHIBIT 32.1 ex32-1.htm EX-32.1 7125
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 20371
5 EXHIBIT 31.1 ex31-1.htm EX-31.1 20130
12 EXHIBIT 10.8 ex10-8.htm EX-10.8 367111
13 EXHIBIT 10.7 ex10-7.htm EX-10.7 2767228
14 EXHIBIT 10.28 ex10-28.htm EX-10.28 304979
15 a1.jpg GRAPHIC 54297
  Complete submission text file 0001437749-16-026076.txt   10412764

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.SCH vbiv-20151231.xsd EX-101.SCH 63561
7 EXHIBIT 101.PRE vbiv-20151231_pre.xml EX-101.PRE 506526
8 EXHIBIT 101.LAB vbiv-20151231_lab.xml EX-101.LAB 396671
9 EXHIBIT 101.INS vbiv-20151231.xml EX-101.INS 1184157
10 EXHIBIT 101.DEF vbiv-20151231_def.xml EX-101.DEF 482557
11 EXHIBIT 101.CAL vbiv-20151231_cal.xml EX-101.CAL 38998
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 6178303031
VBI VACCINES INC. (Filer) CIK: 0000704159 (see all company filings)

IRS No.: 930589534 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-18188 | Film No.: 161457113
SIC: 2836 Biological Products, (No Diagnostic Substances)